TAMPA, Fla. (May 12, 2009) – Kforce Clinical Research Inc., a provider of clinical trial resourcing solutions and a division of Kforce Inc. (NASDAQ: KFRC), has won the 2008 Pfizer Development Operations’ “Strategic Supplier Excellence Award.” The annual award recognizes functional service providers that have demonstrated consistent performance in the areas of quality, service delivery and reliability, innovation and business processes and customer service.
“This recognition is the direct result of the efforts and accomplishments of our tremendously talented and dedicated team members,” said Randy Kehrmeyer, president of Kforce Clinical Research. “We are driven by a shared belief that we have an opportunity – and an obligation – to make a meaningful impact in the lives of our employees, clients and ultimately the countless patients in need of the medicines we are working together to develop.”
Kforce Clinical Research managed project deliverables for more than 200 Pfizer studies consistently throughout the year. Applying the principals of Lean Six Sigma, Kforce streamlined business processes across the U.S. and provided Pfizer with a more consultative view into project staffing and overall protocol management. Kforce also instituted a new business model for site selection that has improved study start-up time.
“Kforce has consistently demonstrated superior performance, adding high value to the U.S. clinical operations business,” said Mike Collins, vice president of clinical study operations at Pfizer. “In addition to exceeding expectations across all award categories, Kforce implemented strong business tools and processes that had meaningful impacts supporting our commitment for continuous improvement within Pfizer.”
Kforce Clinical Research www.kforce.com/clinicalresearch provides customized and flexible functional outsourcing solutions to the biopharmaceutical industry. It specializes in clinical monitoring, site and study management, drug safety, regulatory, clinical data management, data entry, clinical programming and biostatistics. Whereas other outsourcing providers either augment a company’s drug trial with people or handle all aspects of the trial, Kforce’s functional outsourcing model offers a flexible, tailored approach developed to mirror each company’s business model and address specific requirements of the drug trial itself.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.